AU2001233710A1 - Method for the rapid detection of whole microorganisms on retaining membranes byuse of chaotropic agents - Google Patents

Method for the rapid detection of whole microorganisms on retaining membranes byuse of chaotropic agents

Info

Publication number
AU2001233710A1
AU2001233710A1 AU2001233710A AU3371001A AU2001233710A1 AU 2001233710 A1 AU2001233710 A1 AU 2001233710A1 AU 2001233710 A AU2001233710 A AU 2001233710A AU 3371001 A AU3371001 A AU 3371001A AU 2001233710 A1 AU2001233710 A1 AU 2001233710A1
Authority
AU
Australia
Prior art keywords
byuse
rapid detection
chaotropic agents
retaining membranes
whole microorganisms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001233710A
Inventor
Roland Maes
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Anda Biologicals SA
Original Assignee
Anda Biologicals SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anda Biologicals SA filed Critical Anda Biologicals SA
Publication of AU2001233710A1 publication Critical patent/AU2001233710A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/24—Methods of sampling, or inoculating or spreading a sample; Methods of physically isolating an intact microorganisms

Abstract

The detection of microorganisms concentrated from body fluids as serum, sputum, pericardiac fluid, urine or other fluid on the surface of retaining membranes by specific partners of reaction that bind to antigenic components of the retained organisms is facilitated when the organisms concentrated on the membrane are treated with a high molar concentration of a chaotropic agent as guanidine, urea, isothiocyanate, thiourea.
AU2001233710A 2000-02-01 2001-01-26 Method for the rapid detection of whole microorganisms on retaining membranes byuse of chaotropic agents Abandoned AU2001233710A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP00870013A EP1122542A1 (en) 2000-02-01 2000-02-01 Method for the rapid detection of whole microorganisms on retaining membranes by use of chaotropic agents
EP00870013 2000-02-01
PCT/EP2001/000829 WO2001057532A1 (en) 2000-02-01 2001-01-26 Method for the rapid detection of whole microorganisms on retaining membranes by use of chaotropic agents

Publications (1)

Publication Number Publication Date
AU2001233710A1 true AU2001233710A1 (en) 2001-08-14

Family

ID=8175698

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001233710A Abandoned AU2001233710A1 (en) 2000-02-01 2001-01-26 Method for the rapid detection of whole microorganisms on retaining membranes byuse of chaotropic agents

Country Status (6)

Country Link
US (1) US6846648B2 (en)
EP (2) EP1122542A1 (en)
AT (1) ATE294393T1 (en)
AU (1) AU2001233710A1 (en)
DE (1) DE60110369T2 (en)
WO (1) WO2001057532A1 (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0304832D0 (en) * 2003-03-04 2003-04-09 Secr Defence Assay method
US20060046305A1 (en) * 2003-10-15 2006-03-02 National University Of Singapore Method and apparatus for detecting analyte with filter
GB2409519B (en) * 2003-12-22 2005-11-09 Prail Price Richardson Diagnos Microorganism detector
EP2021018A4 (en) * 2006-05-18 2009-06-03 Daniel G Ericson Rapid detection of mycobacterium tuberculosis and antimicrobial drug resistance
US20090181078A1 (en) * 2006-09-26 2009-07-16 Infectious Disease Research Institute Vaccine composition containing synthetic adjuvant
DK2468300T3 (en) 2006-09-26 2018-01-29 Infectious Disease Res Inst Vaccine composition containing synthetic adjuvant
CN102481312B (en) 2009-06-05 2015-07-15 传染性疾病研究院 Synthetic Glucopyranosyl Lipid Adjuvants
CN103596586A (en) 2011-04-08 2014-02-19 免疫设计公司 Immunogenic compositions and methods of using the compositions for inducing humoral and cellular immune responses
HUE044841T2 (en) 2012-02-07 2019-11-28 Infectious Disease Res Inst Improved adjuvant formulations comprising tlr4 agonists and methods of using the same
ES2787455T3 (en) 2012-05-16 2020-10-16 Immune Design Corp HSV-2 vaccines
JP6091158B2 (en) * 2012-10-23 2017-03-08 デンカ生研株式会社 Method to increase sensitivity of immunoassay system by pretreatment of urine with denaturant
AU2014253791B2 (en) 2013-04-18 2019-05-02 Immune Design Corp. GLA monotherapy for use in cancer treatment
US9463198B2 (en) 2013-06-04 2016-10-11 Infectious Disease Research Institute Compositions and methods for reducing or preventing metastasis
AU2014373928C1 (en) 2013-12-31 2020-12-17 Access To Advanced Health Institute Single vial vaccine formulations
CN105759038A (en) * 2016-04-15 2016-07-13 肖乐义 Immunoassay method and kit for assaying mycobacterium tuberculosis from biological samples
CN105717310A (en) * 2016-04-15 2016-06-29 肖乐义 Immuno-fluorescent staining method for detecting mycobacterium tuberculosis in leukocytes and kit
MX2021010105A (en) 2016-06-01 2022-06-16 Infectious Disease Res Inst Nanoalum particles containing a sizing agent.
GB201703383D0 (en) 2017-03-02 2017-04-19 Gargle Tech Ltd Testing for particulates
JP7454264B2 (en) 2018-09-05 2024-03-22 ヒーロー サイエンティフィック リミテッド particle inspection
MX2021014363A (en) 2019-05-25 2022-02-21 Infectious Disease Res Inst Composition and method for spray drying an adjuvant vaccine emulsion.
EP4165385B1 (en) 2021-01-06 2024-04-17 Hero Scientific Ltd Filtration sampling devices

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5482834A (en) * 1982-05-17 1996-01-09 Hahnemann University Evaluation of nucleic acids in a biological sample hybridization in a solution of chaotrophic salt solubilized cells
US4695537A (en) * 1982-05-21 1987-09-22 The University Of Tennessee Research Corp. Particles sensitized with detergent-treated antigen for agglutination immunoassay
US4808518A (en) * 1985-02-11 1989-02-28 University Of Tennessee Research Corporation Recovery of cytomegalovirus antigen and use thereof in an assay
CA1278259C (en) * 1986-02-26 1990-12-27 William C. Saxinger Competitive elisa for the detection of antibodies
US4959303A (en) * 1987-12-21 1990-09-25 Syntex (U.S.A.) Inc. Assay for antigens by binding immune complexes to solid supports free of protein and non-ionic binders
US4978613A (en) * 1989-01-17 1990-12-18 Abbott Laboratories Beta-lactamase assay employing chromogenic precipitating substrates
US5155023A (en) * 1990-02-09 1992-10-13 Synbiotics Corporation Enzyme immunoassay procedure for amphipathic analytes
US5420017A (en) * 1991-01-24 1995-05-30 Orion Corporation Ltd. Method and kit for the detection of microorganisms

Also Published As

Publication number Publication date
US20030022160A1 (en) 2003-01-30
ATE294393T1 (en) 2005-05-15
EP1122542A1 (en) 2001-08-08
EP1252518A1 (en) 2002-10-30
US6846648B2 (en) 2005-01-25
DE60110369D1 (en) 2005-06-02
DE60110369T2 (en) 2006-03-09
WO2001057532A1 (en) 2001-08-09
EP1252518B1 (en) 2005-04-27

Similar Documents

Publication Publication Date Title
AU2001233710A1 (en) Method for the rapid detection of whole microorganisms on retaining membranes byuse of chaotropic agents
DK1036082T3 (en) Isolation of nucleic acids
DE3069608D1 (en) A stabilized aqueous coenzyme solution for use in a clinical assay, a method of stabilizing a labile coenzyme in an aqueous clinical assay solution and a kit for use in said clinical assay
EP1940528A4 (en) Process using rare earths to remove oxyanions from aqueous streams
WO2005030984A3 (en) Method for small volume nucleic acid synthesis
NO912169D0 (en) AMPLIFIED DNA ASSAY.
WO2002101042A1 (en) Method of stabilizing reagent for amplifying or detecting nucleic acid and storage method
WO2006119419A3 (en) Materials and kits for use in hot-start pcr, and methods of amplifying nucleic acids in a polymerase chain reaction
DE60220281D1 (en) PROCESS FOR PREPARING REDUCED COENZYME Q10
ATE340634T1 (en) METHOD FOR REDUCING A TENDENCE OF ADSORPTION OF MOLECULES OR BIOLOGICAL CELLS TO A MATERIAL SURFACE
ATE25707T1 (en) MICROORGANISMS OF THE GENUS PSEUDOMONAS AND PROCESSES FOR DEGRADING METHYL GROUP-CONTAINING COMPOUNDS IN AQUEOUS SOLUTIONS.
DE3380032D1 (en) Process for the immobilisation of microorganisms on a plastic carrier, a plastic carrier on which microorganisms have been immobilised and the use of it in biological reactors
BR9607844A (en) Reagent stabilized using reduction system
RU97117899A (en) REAGENT FOR THE ENZYMATIVE DETERMINATION OF THE CONCENTRATION OF ANALYTED SUBSTANCE, METHOD OF DETERMINING THE CONCENTRATION OF ANALYZED SUBSTANCE
WO2002083931A3 (en) Method for fixing biomolecules onto chemically inert surfaces
CN109289503A (en) A kind of method for treating ammonia-containing waste gas
EP1386621A4 (en) Method of diminishing urine odor and article functioning to diminish urine odor
CA1036965A (en) Method of immobilizing an enzyme
EP0751226A3 (en) Process for amplifying nucleic acid sequences
ES2182445T3 (en) SYSTEM FOR REDUCING INTERFERENCES IN IMMUNOENSAYS.
EP0388171A3 (en) Methods for purification, amplification and detection of a nucleic acid
AU1493995A (en) Monoclonal antibody
SU1174387A1 (en) Method of biochemical removing of cyanides from sewage
AU2002364407A1 (en) Method for detecting catalytic activity
HUP9903456A2 (en) Preparation of chemically immobilized humic acid or fulvic acid on silica gel as a solid phase in liquid chromatography